ovilis enzovax injekční suspenze
intervet international, b.v. - chlamydie vakcíny - injekční suspenze - Živé bakteriální vakcíny - ovce
purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - imunopreparát pro felidae, - kočky - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. nástup imunity byl prokázán jeden týden po primovakcinaci proti rhinotracheitidě, kalicivirové infekci chlamydophila felis a infekční panleukopenii komponenty. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - imunopreparát pro felidae, - kočky - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
biosuis respi e injekční emulze
bioveta, a.s. - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - injekční emulze - imunopreparÁt pro suidae - prasata
azyter 15mg/g oční kapky, roztok
laboratoires thea, clermont-ferrand array - 10264 dihydrÁt azithromycinu - oční kapky, roztok - 15mg/g - azithromycin
doxyvit 40 % prášek pro perorální roztok
lavet pharmaceuticals ltd. - doxycyklin - prášek pro perorální roztok - 40% - tetracykliny - brojleři kura domácího, krůty, prasata
tetrasol la 200 mg/ml injekční roztok
univet, ltd. - oxytetracyklin - injekční roztok - 200mg/ml - tetracykliny - prasata, ovce, skot
doxyvit 100 mg/g prášek pro perorální roztok
ceva animal health slovakia s.r.o. (2) - doxycyklin - prášek pro perorální roztok - tetracykliny - brojleři kura domácího, prasata, krůty, husy
vetracyclin la 200 mg/ml injekční roztok
univet, ltd. - oxytetracyklin - injekční roztok - tetracykliny - skot, ovce, prasata
azithromycin aurovitas 500mg potahovaná tableta
aurovitas, spol. s r.o., praha ČeskÁ republika - 10264 dihydrÁt azithromycinu - potahovaná tableta - 500mg - azithromycin